About GPO   |   Newsroom/Media   |   Congressional Relations   |   Inspector General   |   Careers   |   Contact   |   askGPO   |   Help  
 
Home   |   Customers   |   Vendors   |   Libraries  

The Electronic Code of Federal Regulations (e-CFR) is a regularly updated, unofficial editorial compilation of CFR material and Federal Register amendments produced by the National Archives and Records Administration's Office of the Federal Register (OFR) and the Government Printing Office.

Parallel Table of Authorities and Rules for the Code of Federal Regulations and the United States Code
Text | PDF

Find, review, and submit comments on Federal rules that are open for comment and published in the Federal Register using Regulations.gov.

Purchase individual CFR titles from the U.S. Government Online Bookstore.

Find issues of the CFR (including issues prior to 1996) at a local Federal depository library.

[2]
 
 

Electronic Code of Federal Regulations

blue pill

e-CFR Data is current as of September 18, 2014

Title 21Chapter ISubchapter APart 14


TITLE 21—Food and Drugs

CHAPTER I—FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES

SUBCHAPTER A—GENERAL

PART 14—PUBLIC HEARING BEFORE A PUBLIC ADVISORY COMMITTEE

rule

Subpart A—GENERAL PROVISIONS

§14.1
Scope.
§14.5
Purpose of proceedings before an advisory committee.
§14.7
Administrative remedies.
§14.10
Applicability to Congress.
§14.15
Committees working under a contract with FDA.
rule

Subpart B—MEETING PROCEDURES

§14.20
Notice of hearing before an advisory committee.
§14.22
Meetings of an advisory committee.
§14.25
Portions of advisory committee meetings.
§14.27
Determination to close portions of advisory committee meetings.
§14.29
Conduct of a hearing before an advisory committee.
§14.30
Chairperson of an advisory committee.
§14.31
Consultation by an advisory committee with other persons.
§14.33
Compilation of materials for members of an advisory committee.
§14.35
Written submissions to an advisory committee.
§14.39
Additional rules for a particular advisory committee.
rule

Subpart C—ESTABLISHMENT OF ADVISORY COMMITTEES

§14.40
Establishment and renewal of advisory committees.
§14.55
Termination of advisory committees.
rule

Subpart D—RECORDS OF MEETINGS AND HEARINGS BEFORE ADVISORY COMMITTEES

§14.60
Minutes and reports of advisory committee meetings.
§14.61
Transcripts of advisory committee meetings.
§14.65
Public inquiries and requests for advisory committee records.
§14.70
Administrative record of a public hearing before an advisory committee.
§14.75
Examination of administrative record and other advisory committee records.
rule

Subpart E—MEMBERS OF ADVISORY COMMITTEES

§14.80
Qualifications for members of standing policy and technical advisory committees.
§14.82
Nominations of voting members of standing advisory committees.
§14.84
Nominations and selection of nonvoting members of standing technical advisory committees.
§14.86
Rights and responsibilities of nonvoting members of advisory committees.
§14.90
Ad hoc advisory committee members.
§14.95
Compensation of advisory committee members.
rule

Subpart F—STANDING ADVISORY COMMITTEES

§14.100
List of standing advisory committees.
rule

Subpart G—TECHNICAL ELECTRONIC PRODUCTS RADIATION SAFETY STANDARDS COMMITTEE

§14.120
Establishment of the Technical Electronic Product Radiation Safety Standards Committee (TEPRSSC).
§14.122
Functions of TEPRSSC.
§14.125
Procedures of TEPRSSC.
§14.127
Membership of TEPRSSC.
§14.130
Conduct of TEPRSSC meeting; availability of TEPRSSC records.
rule

Subpart H—COLOR ADDITIVE ADVISORY COMMITTEES

§14.140
Establishment of a color additive advisory committee.
§14.142
Functions of a color additive advisory committee.
§14.145
Procedures of a color additive advisory committee.
§14.147
Membership of a color additive advisory committee.
§14.155
Fees and compensation pertaining to a color additive advisory committee.
rule

Subpart I—ADVISORY COMMITTEES FOR HUMAN PRESCRIPTION DRUGS

§14.160
Establishment of standing technical advisory committees for human prescription drugs.
§14.171
Utilization of an advisory committee on the initiative of FDA.
§14.172
Utilization of an advisory committee at the request of an interested person.
§14.174
Advice and recommendations in writing.


For questions or comments regarding e-CFR editorial content, features, or design, email ecfr@nara.gov.
For questions concerning e-CFR programming and delivery issues, email webteam@gpo.gov.